Medicare Coverage for Next-Generation Sequencing Tests Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests. by Ashley P. Taylor BRCA: Who Should Be Tested? Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out. by Sue Rochman Our Own Words People with cancer and their loved ones find ways for their voices to be heard without filters. by Bradley Jones Finding Support in Unlikely Places After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles. by Patricia Anne Ward Advocacy Spotlight: Sorting Out Priorities Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions. by Cici Zhang Forward Look Little Consensus on Ovarian Cancer Monitoring Tests and scans may be overused. by Kate Yandell Survivor Profile Going Full Bore Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense. by Sue Rochman Forward Look Identifying Ovarian Cancer Risk Study may help spotlight women who would benefit from risk reduction strategies. by Carrie Printz Healthy Habits A Cup of Tea? Black tea consumption may be associated with a reduced risk of ovarian cancer. by Kurt Ullman First Person Never Alone: A Family Journey A mother and daughter exchange thoughts about their “full-family experience” facing an ovarian cancer diagnosis and treatment. by Mary (Dicey) Jackson Scroggins and Nneka Scroggins next Cancer Talk Cancer Care Moves Forward Amid COVID-19 Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care. by Kate Yandell Trials Interrupted COVID-19 slowed or stopped enrollment in some cancer clinical trials. by Kate Yandell Registries Report on COVID-19 and Cancer Data shed light on risk factors for death among people with cancer infected with the coronavirus. by Kate Yandell When COVID-19 Comes Home I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19. by Adam Hayden More Posts